Brett S J, Gao X M, Liew F Y, Tite J P
Department of Cell Biology, Wellcome Research Laboratories, Beckenham, Kent, United Kingdom.
J Immunol. 1991 Sep 1;147(5):1647-52.
In the present study, we have compared the T cell antigenic determinants on nucleoprotein (NP) of influenza A/NT/60/68 virus recognized by BALB/c mice (H-2d) after vaccination using several different vehicles with the determinants recognized after exposure to infectious virus. Mice were immunized s.c. with: 1) purified recombinant NP with three different adjuvants--alum, saponin, or CFA; 2) whole inactivated A/Okuda virus in PBS or saponin; or 3) live attenuated Salmonella typhimurium AroA- vector expressing NP. A series of overlapping synthetic peptides that cover more than 90% of the amino acid sequence of NP were used to map the Th cell epitopes. The results showed that the same limited number of major epitopes were recognized after each of the different immunization regimes. Secondary in vivo boosting using the same vehicles as for the primary immunization did not increase the number of different T cell sites recognized. The T cell responses after intranasal infection with infectious A/NT/60/68 or A/PR/8/34 virus also showed a similar pattern of recognition of the major CD4-positive T cell epitopes. The only exception was that the region corresponding to residues 401-419 was only recognized after exposure to NP from A/NT/60/68 but not A/PR/8/34. This is probably because the two viruses differ in amino acid sequence at positions 408 and 411 within this part of the NP molecule. In contrast to the results observed with CD4-positive T cell epitopes, the major determinant recognized by CD8-positive T cells was only presented after live viral infection. The results in this study have important implications for vaccine design, inasmuch as they indicate that the same dominant CD4 T cell determinants on NP presented by vaccination with NP are also recognized by T cells from mice exposed to infectious virus.
在本研究中,我们比较了BALB/c小鼠(H-2d)在接种疫苗后,使用几种不同载体所识别的甲型流感病毒A/NT/60/68核蛋白(NP)上的T细胞抗原决定簇,以及接触感染性病毒后所识别的决定簇。小鼠通过皮下注射进行免疫:1)用三种不同佐剂(明矾、皂苷或弗氏完全佐剂)纯化的重组NP;2)在PBS或皂苷中的全灭活A/奥久田病毒;或3)表达NP的减毒活鼠伤寒沙门氏菌AroA载体。使用一系列覆盖NP氨基酸序列90%以上的重叠合成肽来定位Th细胞表位。结果表明,在每种不同的免疫方案后,识别出的主要表位数量有限且相同。使用与初次免疫相同的载体进行体内二次加强免疫,并未增加所识别的不同T细胞位点的数量。用感染性A/NT/60/68或A/PR/8/34病毒进行鼻内感染后的T细胞反应,也显示出对主要CD4阳性T细胞表位的类似识别模式。唯一的例外是,对应于401-419位残基的区域仅在接触A/NT/60/68的NP后被识别,而不是A/PR/8/34的NP。这可能是因为这两种病毒在NP分子这部分的408和411位氨基酸序列不同。与CD4阳性T细胞表位的结果相反,CD8阳性T细胞识别的主要决定簇仅在活病毒感染后才出现。本研究结果对疫苗设计具有重要意义,因为它们表明,接种NP疫苗所呈现的NP上相同的显性CD4 T细胞决定簇,也被接触感染性病毒的小鼠的T细胞所识别。